Stonebridge Financial Group
IBB icon

Stonebridge Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Stonebridge Financial Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,305
Closed -$248K – 305
2026
Q2 		$248K Buy
+1,305
New +$224K 0.03% 256

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Commerce Bank
Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Stonebridge Financial Group's IBB Position: Q3 2026 in Review

Stonebridge Financial Group sold out of iShares Biotechnology ETF (IBB) in Q3 2026, closing a stake of 1,305 shares — an estimated $248K sold.

Stonebridge Financial Group first reported a position in IBB in Q2 2026 and held it in 1 quarter. The position peaked at $248K in Q2 2026. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Stonebridge Financial Group reported no remaining iShares Biotechnology ETF position as of Q3 2026 after selling out during the quarter.
  • Stonebridge Financial Group sold 1,305 iShares Biotechnology ETF shares in Q3 2026, an estimated $248K.
  • Stonebridge Financial Group first reported a position in iShares Biotechnology ETF in Q2 2026 and held it in 1 quarter.
  • Stonebridge Financial Group's iShares Biotechnology ETF position peaked at $248K in Q2 2026.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Stonebridge Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.